Join CEO of Stealth Biotherapeutics Reenie McCarthy, and special guest Shelley Bowen, Director of Family Services and Advocacy for the Barth Syndrome Foundation, as they discuss the health equity challenges faced within the ultra-rare disease space, particularly for mitochondrial targeted therapies, and the potential solutions to overcome these obstacles in therapy development.